Amundi
CVS icon

Amundi’s CVS Health CVS Stock Holding History

Amundi’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$778M Buy
7,525,080
+154,142
+2% +$13.8M 0.19% 89
2026
Q1 		$529M Buy
7,370,938
+1,542,655
+26% +$119M 0.14% 131
2025
Q4 		$463M Sell
5,828,283
-1,625,697
-22% -$128M 0.13% 163
2025
Q3 		$573M Buy
7,453,980
+3,637,943
+95% +$249M 0.18% 101
2025
Q2 		$255M Sell
3,816,037
-948,300
-20% -$62.2M 0.09% 219
2025
Q1 		$322M Sell
4,764,337
-2,295,578
-33% -$137M 0.12% 179
2024
Q4 		$324M Buy
7,059,915
+1,165,992
+20% +$65.4M 0.11% 175
2024
Q3 		$387M Buy
5,893,923
+3,404,002
+137% +$199M 0.14% 150
2024
Q2 		$143M Sell
2,489,921
-1,718,426
-41% -$107M 0.05% 297
2024
Q1 		$292M Sell
4,208,347
-167,167
-4% -$12.8M 0.13% 174
2023
Q4 		$352M Sell
4,375,514
-106,817
-2% -$7.6M 0.16% 150
2023
Q3 		$321M Sell
4,482,331
-1,419,806
-24% -$101M 0.16% 148
2023
Q2 		$412M Sell
5,902,137
-1,891,167
-24% -$135M 0.21% 116
2023
Q1 		$606M Buy
7,793,304
+2,994,990
+62% +$251M 0.33% 69
2022
Q4 		$431M Sell
4,798,314
-48,846
-1% -$4.71M 0.24% 112
2022
Q3 		$487M Buy
4,847,160
+2,281,883
+89% +$226M 0.29% 84
2022
Q2 		$238M Buy
2,565,277
+51,185
+2% +$5M 0.19% 137
2022
Q1 		$260M Buy
2,514,092
+16,335
+0.7% +$1.72M 0.18% 140
2021
Q4 		$263M Buy
2,497,757
+786,919
+46% +$72.7M 0.17% 148
2021
Q3 		$145M Sell
1,710,838
-703,602
-29% -$58.9M 0.1% 223
2021
Q2 		$201M Buy
+2,414,440
New +$198M 0.14% 172

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Amundi's CVS Position: Q2 2026 in Review

Amundi increased its CVS Health (CVS) stake by 2.1% in Q2 2026, buying an estimated $13.8M and bringing the position to 7,525,080 shares worth $778M. The position accounts for 0.19% of the portfolio, ranked #89.

Amundi first reported a position in CVS in Q2 2021 and has held it in 21 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Amundi held 7,525,080 shares of CVS Health worth $778M as of Q2 2026.
  • Amundi bought 154,142 CVS Health shares in Q2 2026, an estimated $13.8M.
  • CVS Health made up 0.19% of Amundi's portfolio in Q2 2026, its #89 holding.
  • Amundi first reported a position in CVS Health in Q2 2021 and has held it in 21 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.